Dermatology
Oxsoralen® Supply Status Update (as of June 18, 2010) Oxsoralen-Ultra (Methoxsalen Capsules, USP, 10mg) is now available again in the United States on a limited supply basis. Valeant recognizes the importance of this drug to you and your patients and has been working diligently in partnership with the FDA to address the drug shortage. We are pleased to resume shipments, and Oxsoralen-Ultra (Methoxsalen Capsules, USP, 10mg) can be obtained for your patients through pharmacies. Please instruct the pharmacy to work with their wholesalers to arrange for shipment. If you have any questions or concerns about product availability, please contact our Customer Care group at 1-800-556-1937 or pharmcs@valeant.com. |
Valeant is working to build a significant dermatology portfolio through both acquisitions and internal growth. Our dermatology products help patients who are suffering from actinic keratoses and skin cancer (Efudex®), acne (Atralin® (tretinoin) Gel 0.05%), psoriasis (Oxsoralen-Ultra®) and those who are looking for a reduction in the appearance of scars (Dermatix™ Ultra), skin-aging (Kinerase®) and apparent pigmentation (Oxsoralen-Ultra®).
In October 2008, Valeant acquired Coria Laboratories, Ltd., and expanded its dermatology product portfolio with 17 prescription and OTC products. In December 2008, Valeant also acquired Dow Pharmaceutical Sciences, Inc., a specialty pharmaceutical company that added six products to its dermatology product pipeline including a recently FDA-approved product for acne, Acanya®, which was launched in March 2009.
In November 2008, Valeant acquired DermaTech Pty Ltd, an Australian specialty pharmaceutical company focused on dermatology products marketed throughout Australia and overseas. These products address common dermatological conditions such as dry, itchy or sensitive skin, acne, eczema, psoriasis, contact dermatitis, insect bites, skin warts and sunburn. This acquisition significantly expands Valeant's Australian specialty dermatology business and complements Valeant's current product portfolio.
For information about Valeant's dermatology products, please visit the individual product Web sites.
www.acanyagel.com
www.kinerase.com
www.atralingel.com
www.oxsoralen-ultra.com
www.cerave.com
www.efudex.com
www.dermatix.com.au
www.dermaveen.com.au